Patent · US Active

Method for prediction of postoperative prognosis and diagnosis kit

US8148090B2 · kind B2 · utility

0Cited by
2References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 17, 2008
Grant dateApr 3, 2012
Priority date
Expiry dateOct 17, 2028

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/54
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention relates to a method for predicting the postoperative prognosis of a lung adenocarcinoma patient with high sensitivity and/or specificity by identifying a protein with an expression level that specifically varies in a lung adenocarcinoma patient, comprising: step (a) of determining expression levels of myosin IIA and/or vimentin in a biological sample collected from a lung adenocarcinoma patient; and step (b) of predicting or determining a prognosis based on the expression levels of myosin IIA and/or vimentin obtained as a result of determination.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.